Fresenius SE KGaAXSWX:FRE 71 EV-to-EBITDA is 8.57 as of Jul. 02, 2026, which is 9% below its 10-year median of 9.37. GuruFocus rates XSWX:FRE with a GF Score™ of 71/100 and a GF Value™ of CHF32.22 (Modestly Overvalued). The stock has 5 warning signs investors should review. Among 507 Healthcare Providers & Services companies, Fresenius SE KGaA ranks better than 61.54% on this metric.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Fresenius SE KGaA's enterprise value is CHF29,259 Mil.
Fresenius SE KGaA's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 was CHF3,415 Mil. Therefore, Fresenius SE KGaA's EV-to-EBITDA for today is 8.57.
The historical rank and industry rank for Fresenius SE KGaA's EV-to-EBITDA or its related term are showing as below:
XSWX:FRE'
s EV-to-EBITDA Range Over the Past 10 Years
Min: 6.98 Med: 9.37 Max: 22.23
Current: 8.64
During the past 13 years, the highest EV-to-EBITDA of Fresenius SE KGaA was 22.23. The lowest was 6.98. And the median was 9.37.
XSWX:FRE's EV-to-EBITDA is ranked better than 61.54% of 507
companies
in the Healthcare Providers & Services industry
Industry Median: 10.87
vs XSWX:FRE: 8.64
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio (TTM).
Fresenius SE KGaA (XSWX:FRE) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Fresenius SE KGaA's PE Ratio (TTM) for today is calculated as:
Fresenius SE KGaA's share price for today is CHF36.15.
Fresenius SE KGaA's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was CHF2.412.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
The historical data trend for Fresenius SE KGaA's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XSWX:FRE vs HCA, THC, DVA: EV-to-EBITDA Comparison
For the Medical Care Facilities subindustry, Fresenius SE KGaA's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Fresenius SE KGaA EV-to-EBITDA vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Fresenius SE KGaA's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Fresenius SE KGaA's EV-to-EBITDA falls into.
Fresenius SE KGaA's current Enterprise Value is CHF29,259 Mil.
Fresenius SE KGaA's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was CHF3,415 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Fresenius SE KGaA (XSWX:FRE) has a EV-to-EBITDA of 8.57 as of Jul. 02, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Fresenius SE KGaA. This is near median its historical median of 9.37. Over the past decade, Fresenius SE KGaA's EV-to-EBITDA has ranged from 6.98 to 22.23. According to the industry distribution chart, Fresenius SE KGaA ranks #195 out of 507 companies in the Healthcare Providers & Services industry, placing it in the top 38.5%.
Is Fresenius SE KGaA's EV-to-EBITDA too high?
Fresenius SE KGaA's current EV-to-EBITDA of 8.57 is near median its 10-year median of 9.37. Over the past 10 years, this metric has ranged from a low of 6.98 to a high of 22.23. The Healthcare Providers & Services industry median EV-to-EBITDA is 10.87. Fresenius SE KGaA's value of 8.57 is 21.2% below this industry median. Based on the distribution chart, Fresenius SE KGaA ranks #195 out of 507 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Fresenius SE KGaA has a GF Score™ of 71/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Fresenius SE KGaA's EV-to-EBITDA compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Fresenius SE KGaA ranks #195 out of 507 companies for EV-to-EBITDA. This puts Fresenius SE KGaA in the upper half of its industry. The industry median EV-to-EBITDA is 10.87. Fresenius SE KGaA's value of 8.57 is 21.2% below this benchmark. Historically, Fresenius SE KGaA's own EV-to-EBITDA has ranged from 6.98 to 22.23 over the past decade. While the company's 10-year median is 9.37 vs. the industry median of 10.87, Fresenius SE KGaA has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Healthcare Providers & Services company?
The median EV-to-EBITDA among Healthcare Providers & Services companies is 10.87, based on 507 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Fresenius SE KGaA's current EV-to-EBITDA of 8.57 is 21.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Fresenius SE KGaA. For the Healthcare Providers & Services industry, the median EV-to-EBITDA is 10.87 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Fresenius SE KGaA's current EV-to-EBITDA is 8.57, which is near median its own 10-year median of 9.37. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fresenius SE KGaA stock overvalued right now?
Based on GuruFocus' analysis, Fresenius SE KGaA (XSWX:FRE) is currently considered Modestly Overvalued. The stock's GF Value™ is CHF32.22, compared to a current price of CHF36.15 — trading 12.2% above its estimated fair value. The current EV-to-EBITDA is 8.57, which is near median its 10-year median of 9.37 and 21.2% below the Healthcare Providers & Services industry median of 10.87. Fresenius SE KGaA's overall GF Score™ is 71/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For Fresenius SE KGaA (XSWX:FRE), the current EV-to-EBITDA is 8.57 as of Jul. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Fresenius SE KGaA (XSWX:FRE) Overvalued in 2026?
Based on GuruFocus' analysis, Fresenius SE KGaA stock appears to be overvalued.
The current stock price of CHF36.15 is trading 12.2% above its estimated GF Value™ of CHF32.22.
GuruFocus considers Fresenius SE KGaA to be Modestly Overvalued.
Key valuation signals for XSWX:FRE:
EV-to-EBITDA: 8.57 (near median its 10-year median of 9.37)
GF Value™: CHF32.22 vs. price of CHF36.15 (12.2% above fair value)
Industry Position: 21.2% below the Healthcare Providers & Services median (#195 of 507)
No single metric tells the full story. See the XSWX:FRE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Fresenius is a healthcare holding company based in Germany. The company owns a minority stake in dialysis service provider and equipment manufacturer Fresenius Medical Care. The Kabi segment manufactures intravenous drugs, nutrition products, infusion and transfusion therapies, and related pumps. The Helios segment operates private hospitals primarily in Germany and Spain.
71GF Score
Get the complete analysis for XSWX:FRE
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:FRE has been successfully added to your 
